Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 EUR | -.--% | -.--% | -.--% |
04-15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
Performance
3 years | -99.93% | ||
5 years | -99.90% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Alternative Medicine
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-.--% | -.--% | -.--% | -.--% | 142K | ||
+1.64% | +3.18% | +39.33% | +28.98% | 6.11B | ||
-1.15% | -3.83% | -18.38% | -42.77% | 4.35B | ||
+0.32% | +0.65% | -9.17% | -2.64% | 3.19B | ||
+3.46% | +1.80% | +3.98% | -26.06% | 3.15B | ||
+0.12% | +3.66% | -3.41% | -25.32% | 2.51B | ||
+5.38% | +0.59% | +48.74% | +43.30% | 1.98B | ||
+0.35% | +3.34% | -4.82% | -37.93% | 1.74B | ||
-1.33% | -1.33% | -1.24% | -11.83% | 1.63B | ||
+1.58% | +4.61% | -8.96% | -36.30% | 1.6B | ||
+2.83% | +4.85% | +39.87% | +10.44% | 1.45B | ||
+0.70% | +2.13% | +37.14% | -11.11% | 1.35B | ||
+1.25% | +1.25% | -20.35% | -23.28% | 1.24B | ||
+0.92% | +3.55% | -1.31% | -30.48% | 1.16B | ||
+1.02% | +2.86% | -10.81% | -19.02% | 1.04B | ||
-0.55% | +3.12% | +31.41% | +40.00% | 1.02B | ||
Average | +1.03% | +2.01% | +7.63% | -9.00% | ||
Weighted average by Cap. | +1.11% | +1.71% | +9.21% | -7.86% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2023 | -.--% | ||
2022 | -99.89% | ||
2021 | -3.69% | ||
2020 | +65.99% | ||
2019 | -34.38% | ||
2018 | -17.80% |
- Stock Market
- Equities
- PILL Stock
- TBF1 Stock
- Quotes Canntab Therapeutics Limited